✦ LIBER ✦

Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting

✍ Scribed by Van Belle, Simon JP; Cocquyt, Veronique

Book ID: 120077653
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 311 KB
Volume: 9
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656560802548463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of aprepitant, the first neu

Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

✍ Richard Hargreaves; Juan Camilo Arjona Ferreira; David Hughes; Jos Brands; Jeff 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views